Hempyreum.org
Local Time
English (UK) Deutsch (DE) Français (FR) Español (ES) Italian (IT)
Review Analyzes 140 Controlled Clinical Cannabis Trials
Author: John McClain 14/06/2017 - 18:18:00

A new literature review has evaluated over 140 clinical trials done since 1975 that focused on the safety and effectiveness of cannabis and cannabinoids. 

Two German researchers compiled the overview of cannabis research, which was published in February  in the journal Critical Reviews of Plant Sciences. The review focused on studies in the past 40 years and covers 8,000 participants. 

The study noted research like this have contributed directly to the creation of various cannabis-based medicines and the legal status of cannabis use in countries. 35 clinical trials alone focused on the use of cannabis or cannabinoids in pain management, and 43 clinical trials focused on cannabis or cannabinoids to combat nausea and appetite loss. 

Clinical trials are key to new medicines being approved by the FDA or other authoritative. The amount of participation in clinical trials and the continuing research of cannabis in a therapeutic setting will continue to drive new accepted uses in the medical sector. 

Review of these clinical studies showed overwhelming evidence in support of using cannabis for conditions such as chronic pain, nausea, vomiting and appetite loss in patients being treated for cancer and other conditions. The study also found some evidence that suggests the therapeutic use of cannabis may treat conditions like irritable bowel syndrome, glaucoma and Crohn’s disease.

There were also small studies that showed potential for treating Post-Traumatic Stress Disorder, attention deficit hyperactivity disorder and more.

The study also studies the amount of research pertaining to two popular cannabinoids, delta-9-tetrahydrocannabinol (THC) and cannabidiol (CBD). The study concluded that the most common side effects of cannabis-based medication containing THC were dry mouth, sedation and dizziness, and psychological effects. Tolerance to side effects usually developed in a brief time, and didn’t pose problems in a therapeutic setting.

Researching the studies that focused on CBD showed the promise it has for treating conditions like epilepsy and schizophrenia with no intoxicating effects.

Original article from ireadculture:Review Analyzes 140 Controlled Clinical Cannabis Trials


©2017 - Hempyreum.org - News about Hemp and Cannabis [Beta] | All rights and ownership of the contents belong to their respective holders

Advertising